Skip to Main Content
CKG
Home
Home
Home
TKG
Paper Details
Breadcrumb
Paper Details
Paper Title
The glutamine antagonist prodrug JHU-083 slows malignant glioma growth and disrupts mTOR signaling.
PubMed
Paper Journal Title
Neuro-Oncology Advances
Paper Citation Count
22
Paper Publication Year
2021
Bio Mention
Cyclin D1 protein, GLS, GLS gene, Glutaminase, Glutaminase (GLS) gene silenced glioma cells, Glutamine, IDH1, IDH1 mut, IDH1 mut glioma, IDH1R132H, IDH1R132H isogenic cells, IDH2, IDHmut, IDHmut glioma, IDHmut glioma cell, Isocitrate, Isocitrate Dehydrogenase 1/2, JHU-083, TSC2, cancer, cancer cell, cancer cell lines, glioblastoma, glioma, glioma cell, glioma cells, glioma grade II and III, glutamine, guanine, isogenic cells, mTOR, malignant glioma, pS6 protein
Mesh Descriptor
Go
Actions
Author Name
Affiliation
Gregory J Riggins
Johns Hopkins University School of Medicine
1 - 1
Column Actions
Search
Datasets